Big Pharma's 'Narrative' Is Failing
Beware harm to federal health agencies
Massey scientist suggests COVID-19 should be treated as an acute inflammatory disease
School reopening plans linked to politics rather than public health
Kodak Soars After Government Loan To End China Medical Supply Chain Reliance
Trump’s tweets advocate hydroxychloroquine as big COVID-19 vaccine trials start
"It Reeks Of Orwell" - The COVID Coup (& How To Unlock Ourselves)
Florida Surpasses New York In Coronavirus Case Tally As US Set To See Deaths Top 1,000 For 5th Day: Live Updates
Why hydroxychloroquine and chloroquine don't block SARS-CoV-2 infection of human lung cells
New CCC19 data offer insights on COVID treatments for people with cancer
Hydroxychloroquine ineffective against mild Covid-19, U.S. study shows
Novartis to provide ‘no profit’ COVID-19 drugs to low-income countries
Artemisinin: fighting coronavirus with this antimalarial drug is risky
Could pressure for COVID-19 drugs lead the FDA to lower its standards?
Basel study: Why lopinavir and hydroxychloroquine do not work on COVID-19
Florida Reports Another 10k COVID-19 Cases As Dozens Of ICUs Are Overwhelmed: Live Updates
US Tops 3 Million COVID-19 Cases As ICUs In Florida, Texas Hit Max Capacity: Live Updates
Trump and Navarro press again for hydroxychloroquine. Can the FDA stay independent?
Retractions and controversies over coronavirus research show that the process of science is working as it should
As Pandemic Continues, World Health Organization Struggles To Maintain Coherent Response
Which drugs and therapies are proven to work, and which ones don't, for COVID-19?
FDA Sets Bar for COVID-19 Vaccine Approval at 50 Percent Effectiveness
Global Hydroxychloroquine Study To Resume After Positive Trial Results
Global COVID-19 prevention trial of hydroxychloroquine to resume
3 "Strong Buy" Coronavirus Stocks With Massive Upside Potential
The real impact of COVID-19 on emerging markets
Many studies of COVID-19 antibody test accuracy fall short: review
UK team awarded grant for ‘second wave’ COVID-19 drug hunt
Coronavirus pharma news roundup – 19/06/20
US left with huge hydroxychloroquine stockpile after COVID-19 trial failures